While our model mechanistically attributes treatment failure to the upregulation of the tumor’s PD-L1 expression, another biologically plausible mechanism that could explain the observed relapse is T-cell exhaustion in the tumor microenvironment [35,36]. This evidence concerns the gene CD274 and neoplasm.